Literature DB >> 16126891

Activation induced cytidine deaminase expression in lymphocyte predominant Hodgkin lymphoma.

A Mottok1, M-L Hansmann, A Bräuninger.   

Abstract

BACKGROUND: The lymphocytic and histiocytic (L&H) cells of lymphocyte predominant Hodgkin lymphoma (HL) originate from germinal centre B cells and carry mutated V gene rearrangements, usually with intraclonal diversity. It is unclear whether intraclonal V gene diversification by somatic hypermutation, which is strictly dependent on the enzyme activation induced cytidine deaminase (AID), is restricted to the early phase of lymphoma clone expansion and later silenced, or whether it remains active throughout malignant proliferation. AIMS: To analyse whether AID is expressed in L&H cells as an indicator of active somatic hypermutation in the tumour cells.
METHODS: L&H cells from lymphocyte predominant HL cases and centroblasts from lymphadenites were micromanipulated and analysed for AID expression by quantitative real time polymerase chain reaction.
RESULTS: The AID transcription level was higher than background in three of the six lymphocyte predominant HL cases, although it was lower than that seen in centroblasts.
CONCLUSIONS: Somatic hypermutation may remain active in L&H cells in a considerable proportion of cases, increasing the risk of acquiring further transforming mutations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16126891      PMCID: PMC1770833          DOI: 10.1136/jcp.2005.026252

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Variable heavy chain gene analysis of follicular lymphomas: correlation between heavy chain isotype expression and somatic mutation load.

Authors:  W M Aarts; R J Bende; E J Steenbergen; P M Kluin; E C Ooms; S T Pals; C J van Noesel
Journal:  Blood       Date:  2000-05-01       Impact factor: 22.113

2.  Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells.

Authors:  A Braeuninger; R Küppers; J G Strickler; H H Wacker; K Rajewsky; M L Hansmann
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

3.  Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells.

Authors:  T Marafioti; M Hummel; I Anagnostopoulos; H D Foss; B Falini; G Delsol; P G Isaacson; S Pileri; H Stein
Journal:  N Engl J Med       Date:  1997-08-14       Impact factor: 91.245

Review 4.  Somatic hypermutation in normal and transformed human B cells.

Authors:  U Klein; T Goossens; M Fischer; H Kanzler; A Braeuninger; K Rajewsky; R Küppers
Journal:  Immunol Rev       Date:  1998-04       Impact factor: 12.988

5.  Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme.

Authors:  M Muramatsu; K Kinoshita; S Fagarasan; S Yamada; Y Shinkai; T Honjo
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

6.  AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity.

Authors:  I S Lossos; R Levy; A A Alizadeh
Journal:  Leukemia       Date:  2004-11       Impact factor: 11.528

7.  Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development.

Authors:  R Küppers; K Rajewsky; M Zhao; G Simons; R Laumann; R Fischer; M L Hansmann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

8.  Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype.

Authors:  Laura A Smit; Richard J Bende; Jan Aten; Jeroen E J Guikema; Wilhelmina M Aarts; Carel J M van Noesel
Journal:  Cancer Res       Date:  2003-07-15       Impact factor: 12.701

9.  Hairy cell leukemia: at the crossroad of somatic mutation and isotype switch.

Authors:  Francesco Forconi; Surinder S Sahota; Donatella Raspadori; Micaela Ippoliti; Gavin Babbage; Francesco Lauria; Freda K Stevenson
Journal:  Blood       Date:  2004-07-29       Impact factor: 22.113

10.  Expression of the AID protein in normal and neoplastic B cells.

Authors:  Laura Pasqualucci; Roberta Guglielmino; Jane Houldsworth; Jessica Mohr; Said Aoufouchi; Roberto Polakiewicz; R S K Chaganti; Riccardo Dalla-Favera
Journal:  Blood       Date:  2004-08-10       Impact factor: 22.113

  10 in total
  2 in total

1.  Clinical observations on chemotherapy curable malignancies: unique genetic events, frozen development and enduring apoptotic potential.

Authors:  Philip Savage
Journal:  BMC Cancer       Date:  2015-01-21       Impact factor: 4.430

2.  APOBEC3B can impair genomic stability by inducing base substitutions in genomic DNA in human cells.

Authors:  Masanobu Shinohara; Katsuhiro Io; Keisuke Shindo; Masashi Matsui; Takashi Sakamoto; Kohei Tada; Masayuki Kobayashi; Norimitsu Kadowaki; Akifumi Takaori-Kondo
Journal:  Sci Rep       Date:  2012-11-13       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.